Tag

Notch Signaling

All articles tagged with #notch signaling

Israeli study identifies rare cochlear cells with potential to reverse hearing loss
science10 days ago

Israeli study identifies rare cochlear cells with potential to reverse hearing loss

Tel Aviv University researchers report that inhibiting Notch signaling can trigger a rare subset of cochlear supporting cells (transdifferentiating Deiters’ cells) to become hair cells, offering a potential path to regenerate hearing. Using live imaging and single-cell multi-omics, the team shows this regenerative capacity exists in humans and could be leveraged with inner-ear injections, though it remains early basic research. Translation to patients will require overcoming regulatory, cost, and safety hurdles, but the work marks a significant step toward treatments that restore hearing rather than simply aiding it.

Single-cell atlas links IBD risk to cell-type specific gene regulation
science1 month ago

Single-cell atlas links IBD risk to cell-type specific gene regulation

Researchers built IBDverse, the largest single-cell eQTL atlas for inflammatory bowel disease, mapping cis-eQTL effects across blood and gut tissues in about 400 individuals to link genetic risk to specific cell types. They find cell-type eQTLs are more distal, enhancer-rich, and far more likely to colocalize with IBD GWAS signals than bulk-tissue eQTLs, nominating effector genes such as MAML2 and ZMIZ1 in dendritic cells and MYC and RASGRP1 in colonocytes. Notch pathway regulators in dendritic cells and Wnt-driven epithelial renewal in colonocytes emerge as key mechanisms, tying regulatory variation to barrier dysfunction and inflammation. The study also highlights therapeutic angles—including PRKCB inhibitors and targets like ITGA4/JAK2—and provides a framework for interpreting GWAS loci via cell-type–resolved eQTL mapping in complex diseases.

Notch Timing Unlocks Lab-Grown Helper and Killer T Cells for Off-the-Shelf Immunotherapy
science5 months ago

Notch Timing Unlocks Lab-Grown Helper and Killer T Cells for Off-the-Shelf Immunotherapy

UBC researchers show that precisely tuning the duration and intensity of Notch signaling in stem cells can reliably steer them to become helper or killer T cells, enabling scalable, off-the-shelf immunotherapies for cancer and other diseases. This overcomes a long-standing bottleneck by producing both T cell types from renewable sources, potentially reducing manufacturing costs and time.